The goal of this clinical trial is to learn if the Fisher Wallace Stimulator FW-200 experimental device is effective at treating self-reported anxiety in first responders. The main question the trial aims to answer is does the FW-200 device improve anxiety as measured by a validated questionnaire.

This is a randomized waitlist-controlled trial to evaluate the efficacy and safety of the Fisher Wallace Stimulator FW-200 device in the treatment of self-reported anxiety in police personnel and first responders. Participants will be randomly assigned to receive immediate treatment or deferred treatment with the FW-200 device.

Inclusion Criteria:

• Age 18 years and older
• Ability to read and write in English
• First responder employee or employee of participating police department
• Beck Anxiety Inventory total score above 7
• Able to commit to two 20-minute device treatment session per day for up to 8 weeks
• Willing to wear an actigraphy device

Exclusion Criteria:

• Use of brain stimulation device in the last year
• Have a pacemaker, electronic stent or electronic implants
• Started or planning to start new medial treatment or health program over the next 8 weeks
• Contemplated suicide in the past year
• Institutionalized for mental health issues
• Have a serious medical condition
• Currently taking medications affecting the nervous system
• Allergic to nickel
• Currently taking or planning to take part in any other study on insomnia, anxiety or other mental health effort over the next 8 weeks
• Currently pregnant or planning to become pregnant in the next 10 weeks